Our research indicates that GFAP is an exceptionally reliable biomarker for differentiating acute stroke from stroke mimics, demonstrating outstanding sensitivity, perfect specificity, and robust positive and negative predictive values. The gene discussed is GFAP; the disease is Stroke.